Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,750 | -4,273 | -14,268 | -9,005 | -5,732 |
| Depreciation Amortization | 36 | 18 | 87 | 74 | 56 |
| Income taxes - deferred | -532 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -295 | 13 | -363 | 368 | -318 |
| Other Working Capital | 115 | -804 | 709 | 546 | -451 |
| Other Operating Activity | 168 | 144 | 945 | -63 | 521 |
| Operating Cash Flow | $-9,258 | $-4,902 | $-12,890 | $-8,080 | $-5,924 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | N/A | -14 | -14 | -14 |
| Net Acquisitions | -3,863 | -3,863 | N/A | N/A | N/A |
| Other Investing Activity | -417 | -417 | 0 | 0 | 0 |
| Investing Cash Flow | $-4,294 | $-4,280 | $-14 | $-14 | $-14 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,376 | -1,376 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 74,002 | 74,002 | 74,002 |
| Financing Cash Flow | $-1,376 | $-1,376 | $74,002 | $74,002 | $74,002 |
| Exchange Rate Effect | -35 | 28 | N/A | N/A | N/A |
| Beginning Cash Position | 67,325 | 67,325 | 6,227 | 6,227 | 6,227 |
| End Cash Position | 52,362 | 56,795 | 67,325 | 72,135 | 74,291 |
| Net Cash Flow | $-14,963 | $-10,530 | $61,098 | $65,908 | $68,064 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,258 | -4,902 | -12,890 | -8,080 | -5,924 |
| Capital Expenditure | -14 | N/A | -14 | -14 | -14 |
| Free Cash Flow | -9,272 | -4,902 | -12,904 | -8,094 | -5,938 |